JP2025085731A5 - - Google Patents
Info
- Publication number
- JP2025085731A5 JP2025085731A5 JP2025040952A JP2025040952A JP2025085731A5 JP 2025085731 A5 JP2025085731 A5 JP 2025085731A5 JP 2025040952 A JP2025040952 A JP 2025040952A JP 2025040952 A JP2025040952 A JP 2025040952A JP 2025085731 A5 JP2025085731 A5 JP 2025085731A5
- Authority
- JP
- Japan
- Prior art keywords
- biodiffusion chamber
- odn
- igf
- biodiffusion
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469003P | 2017-03-09 | 2017-03-09 | |
| US62/469,003 | 2017-03-09 | ||
| US201862629972P | 2018-02-13 | 2018-02-13 | |
| US62/629,972 | 2018-02-13 | ||
| JP2019548594A JP7681285B2 (ja) | 2017-03-09 | 2018-03-09 | アンチセンスを用いて癌を治療するための方法及び組成物 |
| PCT/US2018/021706 WO2018165528A1 (en) | 2017-03-09 | 2018-03-09 | Methods and compositions for treating cancers using antisense |
| JP2023030687A JP7656350B2 (ja) | 2017-03-09 | 2023-03-01 | アンチセンスを用いて癌を治療するための方法及び組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023030687A Division JP7656350B2 (ja) | 2017-03-09 | 2023-03-01 | アンチセンスを用いて癌を治療するための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025085731A JP2025085731A (ja) | 2025-06-05 |
| JP2025085731A5 true JP2025085731A5 (https=) | 2025-12-09 |
Family
ID=62838976
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548594A Active JP7681285B2 (ja) | 2017-03-09 | 2018-03-09 | アンチセンスを用いて癌を治療するための方法及び組成物 |
| JP2023030687A Active JP7656350B2 (ja) | 2017-03-09 | 2023-03-01 | アンチセンスを用いて癌を治療するための方法及び組成物 |
| JP2025040952A Pending JP2025085731A (ja) | 2017-03-09 | 2025-03-14 | アンチセンスを用いて癌を治療するための方法及び組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548594A Active JP7681285B2 (ja) | 2017-03-09 | 2018-03-09 | アンチセンスを用いて癌を治療するための方法及び組成物 |
| JP2023030687A Active JP7656350B2 (ja) | 2017-03-09 | 2023-03-01 | アンチセンスを用いて癌を治療するための方法及び組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US10357509B2 (https=) |
| EP (2) | EP4378531A3 (https=) |
| JP (3) | JP7681285B2 (https=) |
| KR (2) | KR102925388B1 (https=) |
| CN (2) | CN118750590A (https=) |
| AU (2) | AU2018230458B2 (https=) |
| BR (1) | BR112019018555A2 (https=) |
| CA (1) | CA3054662A1 (https=) |
| IL (2) | IL316679A (https=) |
| MX (2) | MX2019010725A (https=) |
| NZ (1) | NZ756820A (https=) |
| RU (1) | RU2766457C2 (https=) |
| SG (2) | SG11201908054XA (https=) |
| WO (1) | WO2018165528A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016164916A1 (en) * | 2015-04-10 | 2016-10-13 | Thomas Jefferson University | Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes |
| CN108291227A (zh) | 2015-10-14 | 2018-07-17 | 拜奥-帕斯控股股份有限公司 | 用于脂质体制剂的对乙氧基核酸 |
| AU2017325971A1 (en) | 2016-09-16 | 2019-04-11 | Bio-Path Holdings, Inc. | Combination therapy with liposomal antisense oligonucleotides |
| US10357509B2 (en) | 2017-03-09 | 2019-07-23 | Thomas Jefferson University | Methods and compositions for treating cancers using antisense |
| EA201992490A1 (ru) | 2017-04-19 | 2020-03-03 | Байо-Пат Холдингз, Инк. | Р-этокси нуклеиновые кислоты для ингибирования bcl2 |
| EA201992485A1 (ru) | 2017-04-19 | 2020-02-17 | Байо-Пат Холдингз, Инк. | Р-этокси нуклеиновые кислоты для ингибирования stat3 |
| CA3089583A1 (en) * | 2018-01-24 | 2019-08-01 | Thomas Jefferson University | Biodiffusion chamber |
| CA3113812A1 (en) * | 2018-09-26 | 2020-04-02 | Thomas Jefferson University | Neoantigen compositions; and methods of preparation and use thereof |
| EP3873497A4 (en) * | 2018-11-02 | 2022-08-03 | Thomas Jefferson University | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BREAST CANCER USING ANTISENSE NUCLEIC ACIDS |
| AU2019374061A1 (en) * | 2018-11-02 | 2021-06-03 | Thomas Jefferson University | Methods and compositions for treating hepatocellular carcinoma using antisense |
| MX2021011760A (es) * | 2019-03-28 | 2021-12-10 | Univ Jefferson | Metodos para el tratamiento de canceres usando antisentido. |
| USD1107915S1 (en) | 2019-07-23 | 2025-12-30 | Thomas Jefferson University | Biodiffusion chamber |
| WO2024077130A1 (en) * | 2022-10-05 | 2024-04-11 | Thomas Jefferson University | Methods and compositions for treating bladder cancer |
| TW202546228A (zh) * | 2024-01-19 | 2025-12-01 | 大陸商維亞臻生物技術（蘇州）有限公司 | 用於抑制胰島素樣生長因子１受體表達的ｒｎａ抑制劑 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0750516A4 (en) | 1993-03-26 | 1998-07-01 | Univ Jefferson | METHOD FOR INHIBITING CELL PROLIFERATION AND TRIGGERING CELL DIFFERENTIATION USING TYPE 1 GROWTH FACTOR RECEPTOR OLIGONUCLEOTIDES |
| US6340674B1 (en) | 1993-03-26 | 2002-01-22 | Thomas Jefferson University | Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| US5714170A (en) | 1994-11-16 | 1998-02-03 | Thomas Jefferson University | Method of inducing resistance to tumor growth |
| US6541036B1 (en) | 1997-05-29 | 2003-04-01 | Thomas Jefferson University | Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR) |
| JP2002522506A (ja) * | 1998-08-13 | 2002-07-23 | トーマス・ジェファーソン・ユニバーシティ | インスリン様増殖因子−ｉ受容体に向けられるオリゴヌクレオチドを用いた腫瘍の処置 |
| US6144553A (en) | 1998-09-09 | 2000-11-07 | Sun Microsystems, Inc. | Refrigeration cooled disk storage assembly |
| US7037335B2 (en) | 2002-11-19 | 2006-05-02 | Eagle Vision, Inc. | Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma |
| WO2004072284A1 (en) | 2003-02-11 | 2004-08-26 | Antisense Therapeutics Ltd | Modulation of insulin like growth factor i receptor expression |
| US7846906B2 (en) | 2003-02-28 | 2010-12-07 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| CA2447400A1 (en) | 2003-09-12 | 2005-03-12 | The Hospital For Sick Children | Brain tumor stem cells |
| US7361168B2 (en) | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| WO2008039874A2 (en) | 2006-09-26 | 2008-04-03 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
| AU2009291203B2 (en) | 2008-09-10 | 2015-01-22 | Life & Brain Gmbh | Peripheral zone tumor cells, methods for their preparation and use |
| ES2677070T3 (es) * | 2010-10-27 | 2018-07-27 | Curna, Inc. | Tratamiento de enfermedades relacionadas con el regulador del desarrollo 1 asociado a interferón (ifrd1) mediante inhibición del transcrito antisentido natural al gen ifrd1 |
| CN105792775B (zh) | 2013-09-24 | 2019-02-19 | 吉纳生命科学公司 | 用于细胞植入物的气体处理的系统 |
| US9872674B2 (en) | 2014-05-07 | 2018-01-23 | Boehringer Laboratories Inc. | Entrapment and containment system for use with a morcellator and method of entrapping and containing material produced during morcellation procedure |
| WO2016164916A1 (en) | 2015-04-10 | 2016-10-13 | Thomas Jefferson University | Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes |
| CA3250034A1 (en) * | 2015-04-23 | 2025-10-30 | Applied Medical Resources Corporation | Systems and methods for tissue removal |
| CN108291227A (zh) | 2015-10-14 | 2018-07-17 | 拜奥-帕斯控股股份有限公司 | 用于脂质体制剂的对乙氧基核酸 |
| US10357509B2 (en) | 2017-03-09 | 2019-07-23 | Thomas Jefferson University | Methods and compositions for treating cancers using antisense |
| CA3089583A1 (en) * | 2018-01-24 | 2019-08-01 | Thomas Jefferson University | Biodiffusion chamber |
-
2018
- 2018-03-09 US US15/917,050 patent/US10357509B2/en active Active
- 2018-03-09 JP JP2019548594A patent/JP7681285B2/ja active Active
- 2018-03-09 IL IL316679A patent/IL316679A/en unknown
- 2018-03-09 SG SG11201908054XA patent/SG11201908054XA/en unknown
- 2018-03-09 AU AU2018230458A patent/AU2018230458B2/en active Active
- 2018-03-09 WO PCT/US2018/021706 patent/WO2018165528A1/en not_active Ceased
- 2018-03-09 EP EP24157422.7A patent/EP4378531A3/en active Pending
- 2018-03-09 RU RU2019130010A patent/RU2766457C2/ru active
- 2018-03-09 CN CN202410470660.XA patent/CN118750590A/zh active Pending
- 2018-03-09 NZ NZ756820A patent/NZ756820A/en unknown
- 2018-03-09 US US15/916,953 patent/US20180256625A1/en not_active Abandoned
- 2018-03-09 SG SG10202109912X patent/SG10202109912XA/en unknown
- 2018-03-09 KR KR1020197029676A patent/KR102925388B1/ko active Active
- 2018-03-09 CA CA3054662A patent/CA3054662A1/en active Pending
- 2018-03-09 EP EP18764973.6A patent/EP3592841B1/en active Active
- 2018-03-09 KR KR1020247023860A patent/KR20240116561A/ko active Pending
- 2018-03-09 IL IL268872A patent/IL268872B2/en unknown
- 2018-03-09 MX MX2019010725A patent/MX2019010725A/es unknown
- 2018-03-09 BR BR112019018555-0A patent/BR112019018555A2/pt unknown
- 2018-03-09 CN CN201880018150.1A patent/CN110832068A/zh active Pending
-
2019
- 2019-07-22 US US16/518,253 patent/US10772904B2/en active Active
- 2019-09-06 MX MX2024008496A patent/MX2024008496A/es unknown
-
2020
- 2020-09-15 US US17/020,879 patent/US11801259B2/en active Active
-
2023
- 2023-03-01 JP JP2023030687A patent/JP7656350B2/ja active Active
- 2023-09-21 US US18/471,355 patent/US20240100078A1/en active Pending
-
2024
- 2024-10-22 AU AU2024227517A patent/AU2024227517A1/en active Pending
-
2025
- 2025-03-14 JP JP2025040952A patent/JP2025085731A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025085731A5 (https=) | ||
| RU2019130010A (ru) | Способы и композиции для лечения рака с помощью антисмысла | |
| JP2024028529A5 (https=) | ||
| JP2002518350A5 (https=) | ||
| CN103006444B (zh) | 一种凝胶材料在牙体牙髓疾病治疗过程中的用途 | |
| KR101163594B1 (ko) | 치아 골 이식재 제조방법 및 그로 인해 제조된 골 이식재 | |
| CN108498858A (zh) | 二硫化钼纳米片原位修饰生物陶瓷支架及其制备方法和应用 | |
| EP1723963A3 (en) | Hapten-conjugated tumour cells | |
| JP2003529608A5 (https=) | ||
| CN113924978B (zh) | 一种芍药苷含量高的芍药愈伤组织提取物的制备方法 | |
| CN105794492A (zh) | 灵芝的培育方法 | |
| CN109124699B (zh) | 一种植发多功能护理仪 | |
| CN106332649A (zh) | 一种提高菊花品质的扦插育苗方法 | |
| CN118286487B (zh) | 一种促进复杂感染伤口愈合的多功能纳米纤维膜的制备方法 | |
| CN104511055A (zh) | 可降解金属材料在制备用于穴位埋植的植入体中的应用 | |
| CN116815107B (zh) | 一种复合合金材料及其制备方法与应用 | |
| CN105052630B (zh) | 防治沉香木虫害的方法 | |
| JPWO2020198587A5 (https=) | ||
| US11471529B2 (en) | Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof | |
| CN111330007B (zh) | 一种增强抗肿瘤免疫反应的组合物及应用 | |
| CN1253596A (zh) | 双程形状记忆器件的制造 | |
| CN107593444A (zh) | 一种青木香的组织培养快繁方法 | |
| CN103518622A (zh) | 一种低大气压力延长新疆雪莲试管苗在低海拔生存时间的方法 | |
| CN101230349A (zh) | 一种获得产莨菪碱和东莨菪碱的木本曼陀罗毛状根的方法 | |
| CN106171437A (zh) | 一种黄芪扦插育苗方法 |